Although no KLK4 SNPs were statistically significantly associated with prostate cancer risk after Bonferroni correction (P<9×10−4), 7 SNPs were associated at the Ptrend<0.05 significance level and the majority of these displayed a modest decrease in prostate cancer risk of around 20%. The gene discussed is KLK4; the disease is prostate cancer.